Shear-Induced Macrophage Secretome Promotes Endothelial Permeability

Insights

Pathological shear stress causes macrophages to increase inflammation and endothelial permeability, contributing to discrete subaortic stenosis (DSS) recurrence. Targeting this macrophage-endothelial cell crosstalk may offer new therapeutic strategies for DSS.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Pathophysiology

Background:

  • Discrete subaortic stenosis (DSS) is a pediatric cardiovascular disease characterized by fibrotic growth in the left ventricular outflow tract (LVOT).
  • High recurrence rates post-surgery suggest complex underlying mechanisms involving hemodynamic shear stress.
  • The impact of shear stress on macrophage-endothelial cell interactions in DSS remains poorly understood.

Purpose of the Study:

  • To investigate the effects of pathological shear stress on human macrophages and their interactions with endothelial cells.
  • To elucidate the role of macrophage-endothelial cell crosstalk in the inflammatory processes relevant to DSS.

Main Methods:

  • Human monocyte-derived macrophages (MDMs) and human aortic endothelial cells (HAECs) were exposed to shear stress.
  • Cellular responses were assessed via gene expression, permeability assays, chemotaxis, and ELISAs.
  • Macrophage-endothelial cell crosstalk was evaluated using conditioned media transfers.

Main Results:

  • Shear stress induced a pro-inflammatory response in MDMs, upregulating TNF and CXCL8.
  • MDM-conditioned media increased HAEC permeability and inflammatory marker expression (VCAM-1, ICAM-1).
  • Macrophage-secreted factors promoted monocyte migration and altered endothelial cell junction proteins (VE-Cadherin, CD31).

Conclusions:

  • Pathological shear stress drives macrophages to release factors that increase endothelial permeability and inflammation.
  • This inflammatory crosstalk likely contributes to fibrosis and recurrence in DSS.
  • Targeting macrophage-endothelial cell interactions presents a potential therapeutic strategy to mitigate DSS fibrosis and improve outcomes.
Abstract

Related Concept Videos